Nanjing YDB Medical Technology Co., Ltd. was established in October 2013with a registered capital of 100 million yuan. The company is located in NanjingGaochun Economic Development Zone and specializes in providing high-end medical devices for cardiovascular, peripheral vascular, and neurovascular interventions.
The company integrates research and development, production, and sales, and has established a comprehensive ISO 13485 quality management system. lt has been awarded the titles of"National High-tech Enterprise","Excellent Private Enterprise inNanjing", "Nanjing Gazelle Enterprise", and "Nanjing Recognized Enterprise Technology Center".And applied for 1 special project of the provincial science and technology plan and 1 special project of the municipal science and technology plan.
The company adheres to the principle of "intervention without implantation", focusing on high-value consumables in the field of pan-vascular vessels, and currentlyhas a total of 6 Class II, 15 Class III products on sale, and 13 Class II/III products under development. The company has more than 50 authorized invention and utility model patents (including 9 invention patents), and is now applying foracceptance of 26 invention patents and 10 utility model patents.
As the leading medical device enterprise introduced by the government of NanjingGaochun, the company acquired a hundred mu of land in the development zone in 2018 to build a 100,000 square meter R&D and production base for the "Panvascular Medical Device Project". The company is committed to further developing acute and chronic coronary heart disease, prevention of cardiogenic stroke, and treatment of ischemic stroke.